<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="25" ids="22693">Barbiturates</z:chebi> are administered in a variety of clinical conditions to control <z:e sem="disease" ids="C0151740" disease_type="Disease or Syndrome" abbrv="">elevated intracranial pressure</z:e> (ICP) </plain></SENT>
<SENT sid="1" pm="."><plain>However, their routine use to treat elevated ICP has been questioned because it may cause severe side effects </plain></SENT>
<SENT sid="2" pm="."><plain>We therefore investigated the effect of high-dose <z:chebi fb="8" ids="29745">barbiturate</z:chebi> therapy on ICP and outcome in patients with severe <z:hpo ids='HP_0002181'>brain edema</z:hpo> after severe middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) or hemispheric infarction </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="8" ids="29745">Barbiturate</z:chebi> <z:hpo ids='HP_0001259'>coma</z:hpo> was induced with <z:chebi fb="0" ids="102166">thiopental</z:chebi> infusion in 60 patients with critically increased ICP due to large hemispheric or <z:chebi fb="70" ids="34342">MCA</z:chebi> territory infarction, defined by CT </plain></SENT>
<SENT sid="4" pm="."><plain>ICP was monitored in <z:hpo ids='HP_0000001'>all</z:hpo> patients during <z:chebi fb="8" ids="29745">barbiturate</z:chebi> therapy </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="8" ids="29745">Barbiturate</z:chebi> <z:hpo ids='HP_0001259'>coma</z:hpo> was induced after a standardized treatment protocol for increased ICP after failure of osmotherapy and mild <z:hpo ids='HP_0002883'>hyperventilation</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>During <z:chebi fb="8" ids="29745">barbiturate</z:chebi> administration, cerebral perfusion pressure (CPP) and mean arterial pressure were recorded </plain></SENT>
<SENT sid="7" pm="."><plain>Clinical outcome of these patients and the individual effect on ICP were analyzed </plain></SENT>
<SENT sid="8" pm="."><plain>Only five of 60 patients who were treated with <z:chebi fb="8" ids="29745">barbiturate</z:chebi> <z:hpo ids='HP_0001259'>coma</z:hpo> survived (8%) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> other patients died after <z:e sem="disease" ids="C0393985" disease_type="Disease or Syndrome" abbrv="">transtentorial herniation</z:e> with subsequent brain <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="8" ids="29745">Barbiturate</z:chebi> infusion was followed by a drop in ICP in 50 patients and showed no effect on ICP values in 10 patients </plain></SENT>
<SENT sid="11" pm="."><plain>CPP decreased with a mean of 9 mm Hg (range, 5 to 20 mm Hg) </plain></SENT>
<SENT sid="12" pm="."><plain>Although <z:chebi fb="25" ids="22693">barbiturates</z:chebi> were initially effective, only in some patients was ICP control sustained </plain></SENT>
<SENT sid="13" pm="."><plain>Severe side effects of <z:chebi fb="8" ids="29745">barbiturate</z:chebi> therapy, besides <z:hpo ids='HP_0002615'>arterial hypotension</z:hpo>, were seen in 15 patients (25%) </plain></SENT>
<SENT sid="14" pm="."><plain><z:chebi fb="8" ids="29745">Barbiturate</z:chebi> <z:hpo ids='HP_0001259'>coma</z:hpo> in the therapy of increased ICP after severe ischemic hemispheric <z:hpo ids='HP_0001297'>stroke</z:hpo> can lower critically elevated ICP levels </plain></SENT>
<SENT sid="15" pm="."><plain>However, it seems to have no positive effect on neurologic outcome </plain></SENT>
</text></document>